Quarterly
Annual
| Unit: USD | 2020-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
increase in: | |||||||||||||||||||||||||||||||||
accounts and notes receivable | |||||||||||||||||||||||||||||||||
contract assets | |||||||||||||||||||||||||||||||||
other current assets | |||||||||||||||||||||||||||||||||
other assets | |||||||||||||||||||||||||||||||||
accounts payable | |||||||||||||||||||||||||||||||||
contract liabilities | |||||||||||||||||||||||||||||||||
accrued liabilities | |||||||||||||||||||||||||||||||||
other liabilities | |||||||||||||||||||||||||||||||||
increase in cash due to changes in assets and liabilities | |||||||||||||||||||||||||||||||||
cash paid during the year for: | |||||||||||||||||||||||||||||||||
interest | |||||||||||||||||||||||||||||||||
income taxes | |||||||||||||||||||||||||||||||||
noncash investing and financing activities: | |||||||||||||||||||||||||||||||||
marketable securities transferred to trustee to discharge the 2024 notes | |||||||||||||||||||||||||||||||||
debt assumed by buyer of stork latin america | |||||||||||||||||||||||||||||||||
information about contract assets: | |||||||||||||||||||||||||||||||||
unbilled receivables - reimbursable contracts | |||||||||||||||||||||||||||||||||
contract work in progress - lump sum contracts | |||||||||||||||||||||||||||||||||
information about contract liabilities: | |||||||||||||||||||||||||||||||||
revenue recognized that was included in contract liabilities as of january 1 | |||||||||||||||||||||||||||||||||
current assets | |||||||||||||||||||||||||||||||||
noncurrent assets | |||||||||||||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||||||||||||
noncurrent liabilities | |||||||||||||||||||||||||||||||||
right-of-use assets | |||||||||||||||||||||||||||||||||
operating lease assets | |||||||||||||||||||||||||||||||||
finance lease assets | |||||||||||||||||||||||||||||||||
total right-of-use assets | |||||||||||||||||||||||||||||||||
lease liabilities | |||||||||||||||||||||||||||||||||
operating lease liabilities, current | |||||||||||||||||||||||||||||||||
operating lease liabilities, noncurrent | |||||||||||||||||||||||||||||||||
finance lease liabilities, current | |||||||||||||||||||||||||||||||||
finance lease liabilities, noncurrent | |||||||||||||||||||||||||||||||||
total lease liabilities | |||||||||||||||||||||||||||||||||
cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||||||||||||||||||||
operating cash flows from operating leases | |||||||||||||||||||||||||||||||||
financing cash flows from finance leases | |||||||||||||||||||||||||||||||||
right-of-use assets obtained in exchange for new operating lease liabilities | |||||||||||||||||||||||||||||||||
right-of-use assets obtained in exchange for new finance lease liabilities | |||||||||||||||||||||||||||||||||
weighted-average remaining lease term - operating leases | |||||||||||||||||||||||||||||||||
weighted-average remaining lease term - finance leases | |||||||||||||||||||||||||||||||||
weighted-average discount rate - operating leases | |||||||||||||||||||||||||||||||||
weighted-average discount rate - finance leases | |||||||||||||||||||||||||||||||||
year ended december 31, | |||||||||||||||||||||||||||||||||
2023 | |||||||||||||||||||||||||||||||||
2024 | |||||||||||||||||||||||||||||||||
2025 | |||||||||||||||||||||||||||||||||
2026 | |||||||||||||||||||||||||||||||||
2027 | |||||||||||||||||||||||||||||||||
thereafter | |||||||||||||||||||||||||||||||||
total lease payments | |||||||||||||||||||||||||||||||||
less: interest | |||||||||||||||||||||||||||||||||
present value of lease liabilities | |||||||||||||||||||||||||||||||||
lease assets / liabilities | |||||||||||||||||||||||||||||||||
operating lease liabilities | |||||||||||||||||||||||||||||||||
finance lease liabilities | |||||||||||||||||||||||||||||||||
cont ops | |||||||||||||||||||||||||||||||||
operating cash flows from finance leases | |||||||||||||||||||||||||||||||||
cash flows from operating activities | |||||||||||||||||||||||||||||||||
net earnings | -729,539,000 | -593,486,000 | -43,308,000 | 77,830,000 | 96,025,000 | 131,164,000 | -12,061,000 | 112,889,000 | -6,632,000 | 77,354,000 | 17,406,000 | 120,054,000 | 119,011,000 | 181,736,000 | 160,744,000 | 165,604,000 | 114,890,000 | 109,980,000 | 193,310,000 | 207,340,000 | 213,256,000 | 172,338,000 | 192,521,000 | 177,175,000 | 161,589,000 | 191,459,000 | 161,213,000 | 178,417,000 | 153,672,000 | 174,004,000 | 176,339,000 | 221,287,000 | |
adjustments to reconcile net earnings to cash provided (utilized) by operating activities: | |||||||||||||||||||||||||||||||||
depreciation of fixed assets | 41,143,000 | 42,607,000 | 45,264,000 | 46,993,000 | 48,089,000 | 50,596,000 | 51,907,000 | 51,960,000 | 51,203,000 | 50,718,000 | 53,725,000 | 54,243,000 | 47,147,000 | 46,266,000 | 46,892,000 | 47,803,000 | 48,962,000 | 46,371,000 | 48,492,000 | 54,155,000 | 54,626,000 | 52,472,000 | 51,270,000 | 51,755,000 | 50,367,000 | 49,198,000 | 48,477,000 | 45,549,000 | 45,948,000 | 45,845,000 | 44,946,000 | 43,687,000 | |
amortization of intangibles | 3,989,000 | 4,476,000 | 4,567,000 | 4,744,000 | 4,924,000 | 4,656,000 | 4,747,000 | 4,554,000 | 4,461,000 | 5,059,000 | 5,233,000 | 6,969,000 | 222,000 | 223,000 | 222,000 | 223,000 | 223,000 | 223,000 | 223,000 | 132,000 | 313,000 | 735,000 | 403,000 | 401,000 | 228,000 | 1,614,000 | 328,000 | 266,000 | 371,000 | 298,000 | 297,000 | 340,000 | |
(earnings) income from equity method investments, net of distributions | -1,381,000 | 5,776,000 | 2,115,000 | 474,000 | -1,413,000 | 65,000 | 1,854,000 | 924,000 | 1,072,000 | -1,570,000 | |||||||||||||||||||||||
gain on sale of joint venture interest | |||||||||||||||||||||||||||||||||
gain on sale of property, plant and equipment | 9,242,000 | -1,694,000 | -1,858,000 | ||||||||||||||||||||||||||||||
impairment of long-lived assets | 308,296,000 | ||||||||||||||||||||||||||||||||
amortization of stock-based awards | -2,290,000 | 16,561,000 | 13,242,000 | 8,294,000 | 10,745,000 | 10,073,000 | 13,917,000 | 8,846,000 | 6,564,000 | 15,666,000 | 7,930,000 | 9,991,000 | 13,921,000 | ||||||||||||||||||||
deferred compensation trust | -2,577,000 | -8,267,000 | -26,145,000 | 1,025,000 | -5,958,000 | 34,280,000 | 20,165,000 | 2,150,000 | 33,604,000 | 8,557,000 | |||||||||||||||||||||||
deferred compensation obligation | -1,766,000 | 8,009,000 | 28,584,000 | -41,592,000 | 16,175,000 | 2,215,000 | 930,000 | 16,861,000 | 4,507,000 | 14,620,000 | 14,797,000 | 4,761,000 | 5,655,000 | -2,995,000 | 6,164,000 | -8,180,000 | 11,797,000 | 4,649,000 | -1,726,000 | 18,093,000 | 13,498,000 | -9,673,000 | 24,988,000 | -2,462,000 | 11,560,000 | 8,509,000 | 22,738,000 | ||||||
deferred taxes | 444,484,000 | -147,939,000 | -25,549,000 | 39,625,000 | 15,350,000 | 22,897,000 | 24,785,000 | 52,081,000 | 34,800,000 | -10,314,000 | 34,286,000 | -68,639,000 | 3,340,000 | 143,601,000 | 23,605,000 | 11,510,000 | 17,424,000 | 26,251,000 | 4,630,000 | 7,789,000 | 29,252,000 | ||||||||||||
net retirement plan accrual | 6,000 | 1,750,000 | -3,577,000 | 3,577,000 | 3,391,000 | ||||||||||||||||||||||||||||
changes in operating assets and liabilities | -99,406,000 | 740,343,000 | -13,928,000 | -79,813,000 | 83,849,000 | 82,779,000 | 106,138,000 | ||||||||||||||||||||||||||
other items | 5,262,000 | 1,660,000 | 3,117,000 | 2,868,000 | 128,000 | -659,000 | 1,941,000 | 611,000 | -2,218,000 | -2,936,000 | 5,792,000 | -3,625,000 | 4,982,000 | 971,000 | 0 | 63,000 | 1,896,000 | 2,265,000 | 3,428,000 | -1,087,000 | 1,415,000 | 5,416,000 | 6,372,000 | -6,367,000 | 9,452,000 | -578,000 | 6,621,000 | 850,000 | -558,000 | 2,569,000 | |||
cash provided (utilized) by operating activities | -24,537,000 | 186,714,000 | 57,377,000 | 370,533,000 | |||||||||||||||||||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||
purchases of marketable securities | -7,756,000 | -15,229,000 | -8,180,000 | ||||||||||||||||||||||||||||||
proceeds from the sales and maturities of marketable securities | 32,959,000 | 40,665,000 | 124,299,000 | 193,973,000 | 11,916,000 | 159,431,000 | 175,784,000 | 49,831,000 | 29,126,000 | 71,900,000 | 69,376,000 | 144,200,000 | 202,286,000 | 103,329,000 | 26,093,000 | 194,635,000 | 68,603,000 | 76,260,000 | 88,643,000 | 177,911,000 | 107,632,000 | 231,774,000 | 294,544,000 | 198,317,000 | 317,694,000 | 152,527,000 | 183,014,000 | 335,963,000 | 479,886,000 | ||||
capital expenditures | -39,218,000 | -52,668,000 | -48,172,000 | ||||||||||||||||||||||||||||||
free cash flows | |||||||||||||||||||||||||||||||||
proceeds from disposal of property, plant and equipment | 31,252,000 | 14,459,000 | 10,720,000 | 20,175,000 | 20,778,000 | 23,591,000 | 16,494,000 | 27,950,000 | 13,256,000 | 14,652,000 | 21,726,000 | 13,166,000 | 25,881,000 | 15,513,000 | 24,985,000 | 29,905,000 | 25,363,000 | 22,548,000 | 24,557,000 | 9,977,000 | 15,702,000 | 15,011,000 | 13,364,000 | 37,248,000 | 14,928,000 | 15,808,000 | 12,883,000 | 7,206,000 | 9,578,000 | 7,557,000 | 7,021,000 | 10,167,000 | |
investments in partnerships and joint ventures | -7,446,000 | -15,055,000 | -12,001,000 | ||||||||||||||||||||||||||||||
return of capital from partnerships and joint ventures | 1,800,000 | ||||||||||||||||||||||||||||||||
proceeds from company owned life insurance | |||||||||||||||||||||||||||||||||
cash provided (utilized) by investing activities | 17,106,000 | 66,882,000 | -84,220,000 | 236,045,000 | |||||||||||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||
dividends paid | -29,384,000 | -29,319,000 | -30,005,000 | ||||||||||||||||||||||||||||||
proceeds from issuance of 4.250% senior notes | |||||||||||||||||||||||||||||||||
repayment of 3.375% senior notes | |||||||||||||||||||||||||||||||||
proceeds from other borrowings | |||||||||||||||||||||||||||||||||
net proceeds from issuance of commercial paper | |||||||||||||||||||||||||||||||||
debt issuance costs | |||||||||||||||||||||||||||||||||
distributions paid to noncontrolling interests | -10,551,000 | -5,420,000 | -10,152,000 | ||||||||||||||||||||||||||||||
capital contributions by noncontrolling interests | 2,760,000 | 3,054,000 | 4,767,000 | 835,000 | 533,000 | 3,395,000 | 365,000 | 522,000 | 544,000 | 3,606,000 | 555,000 | 6,771,000 | 1,245,000 | 1,334,000 | 1,596,000 | 698,000 | 2,020,000 | 144,000 | 46,000 | 1,260,000 | 202,000 | ||||||||||||
taxes paid on vested restricted stock | 0 | -23,000 | -3,549,000 | ||||||||||||||||||||||||||||||
stock options exercised | 0 | 0 | 1,466,000 | 88,000 | 1,787,000 | 1,364,000 | 4,019,000 | 507,000 | 2,509,000 | 5,787,000 | 171,000 | 463,000 | 2,681,000 | 0 | 239,000 | 923,000 | 8,583,000 | 1,308,000 | 14,070,000 | 6,095,000 | 5,807,000 | 4,464,000 | 689,000 | 5,002,000 | 0 | 5,129,000 | 20,214,000 | 1,104,000 | 527,000 | 1,672,000 | 167,000 | 552,000 | |
cash utilized by financing activities | -29,331,000 | -27,989,000 | -29,820,000 | ||||||||||||||||||||||||||||||
effect of exchange rate changes on cash | -28,989,000 | -5,660,000 | 20,571,000 | 8,978,000 | 4,930,000 | 16,553,000 | 20,667,000 | 22,077,000 | 14,845,000 | -19,282,000 | 24,348,000 | 15,507,000 | 34,960,000 | 4,855,000 | 20,877,000 | ||||||||||||||||||
increase in cash and cash equivalents | -52,181,000 | 51,508,000 | 41,031,000 | 117,145,000 | 56,668,000 | ||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 1,764,746,000 | 0 | 0 | 1,804,075,000 | 0 | 0 | 1,850,436,000 | 0 | 0 | 1,949,886,000 | 0 | 0 | 1,993,125,000 | 0 | 0 | 2,283,582,000 | 0 | 2,154,541,000 | 0 | 0 | 2,161,411,000 | 0 | 0 | 2,134,997,000 | 0 | 1,687,028,000 | 0 | 0 | 1,834,324,000 | ||
cash and cash equivalents at end of period | -52,181,000 | 51,508,000 | 1,805,777,000 | -2,164,000 | -3,994,000 | 1,685,954,000 | 7,230,000 | -147,782,000 | 1,967,581,000 | 153,320,000 | -70,437,000 | 1,697,491,000 | 57,639,000 | -87,533,000 | 1,811,293,000 | -282,612,000 | 40,751,000 | 2,142,058,000 | 90,276,000 | 2,014,800,000 | 347,457,000 | -118,717,000 | 1,922,286,000 | 440,324,000 | -245,700,000 | 2,191,665,000 | -171,871,000 | 1,608,989,000 | 146,123,000 | -288,432,000 | 1,470,326,000 | ||
cash from investing activities | -23,754,000 | 67,756,000 | |||||||||||||||||||||||||||||||
cash utilized by operating activities | -17,476,000 | ||||||||||||||||||||||||||||||||
statute expirations and tax settlements | |||||||||||||||||||||||||||||||||
cash from operating activities | 122,711,000 | 157,691,000 | 270,235,000 | 361,940,000 | -24,111,000 | 114,655,000 | 366,234,000 | 164,907,000 | 39,282,000 | -18,380,000 | 428,639,000 | 159,980,000 | 303,868,000 | 76,085,000 | |||||||||||||||||||
proceeds from sale of joint venture interest | |||||||||||||||||||||||||||||||||
acquisitions, net of cash acquired | |||||||||||||||||||||||||||||||||
repurchase of common stock | |||||||||||||||||||||||||||||||||
proceeds from issuance of senior notes | |||||||||||||||||||||||||||||||||
repayment of 3.375% senior notes and stork notes | |||||||||||||||||||||||||||||||||
borrowings under revolving lines of credit | -462,000 | 123,750,000 | 760,000,000 | ||||||||||||||||||||||||||||||
repayment of borrowings under revolving lines of credit | |||||||||||||||||||||||||||||||||
decrease in cash and cash equivalents | |||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | |||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||||||||||||||
cash utilized by investing activities | |||||||||||||||||||||||||||||||||
net proceeds from issuance of commerical paper | |||||||||||||||||||||||||||||||||
proceeds from issuance of 1.75% senior notes | 0 | 0 | 552,958,000 | ||||||||||||||||||||||||||||||
repayment of stork notes and other borrowings | |||||||||||||||||||||||||||||||||
cash provided (utilized) by financing activities | -70,632,000 | -2,380,000 | 170,821,000 | ||||||||||||||||||||||||||||||
income from discontinued operations, net of taxes | 113,859,000 | ||||||||||||||||||||||||||||||||
gain related to a partial sale of a subsidiary | |||||||||||||||||||||||||||||||||
cash outflows from discontinued operations | |||||||||||||||||||||||||||||||||
proceeds from a partial sale of a subsidiary | |||||||||||||||||||||||||||||||||
repayment of stork notes, convertible debt and other borrowings | |||||||||||||||||||||||||||||||||
repayment of borrowing under revolving lines of credit | |||||||||||||||||||||||||||||||||
loss on sales of equity method investments | |||||||||||||||||||||||||||||||||
earnings from equity method investments, net of distributions | |||||||||||||||||||||||||||||||||
restricted stock and stock option amortization | 13,650,000 | 15,228,000 | 12,546,000 | 12,495,000 | 12,969,000 | 10,792,000 | 11,221,000 | 9,638,000 | 9,518,000 | 9,976,000 | 8,746,000 | 8,618,000 | 8,108,000 | 11,825,000 | 13,330,000 | 9,630,000 | 8,483,000 | 8,633,000 | 8,209,000 | ||||||||||||||
excess tax benefit from stock-based plans | 867,000 | 108,000 | 742,000 | 3,115,000 | 671,000 | 2,747,000 | 394,000 | 480,000 | 3,444,000 | ||||||||||||||||||||||||
proceeds from sales of equity method investments | 0 | ||||||||||||||||||||||||||||||||
repayment of convertible debt and other borrowings | |||||||||||||||||||||||||||||||||
gain on sales of equity method investments | 0 | ||||||||||||||||||||||||||||||||
net retirement plan (contributions) accrual | |||||||||||||||||||||||||||||||||
consolidation of a variable interest entity | 0 | 24,675,000 | |||||||||||||||||||||||||||||||
acquisitions | |||||||||||||||||||||||||||||||||
repayment of 5.625% municipal bonds | |||||||||||||||||||||||||||||||||
repayment of convertible debt and notes payable | |||||||||||||||||||||||||||||||||
losses from equity method investments, net of distributions | |||||||||||||||||||||||||||||||||
retirement plan contributions, net of accruals | |||||||||||||||||||||||||||||||||
losses (earnings) from equity method investments, net of distributions | 2,784,000 | ||||||||||||||||||||||||||||||||
gain on sale of an equity method investment | |||||||||||||||||||||||||||||||||
retirement plan accrual, net of contributions | 3,360,000 | 4,211,000 | 190,000 | 10,666,000 | 5,631,000 | 13,511,000 | 7,716,000 | 7,881,000 | 15,700,000 | 4,342,000 | |||||||||||||||||||||||
undistributed earnings of equity method investments | |||||||||||||||||||||||||||||||||
proceeds from sale of an equity method investment | |||||||||||||||||||||||||||||||||
adjustments to reconcile net earnings to cash (utilized) provided by operating activities: | |||||||||||||||||||||||||||||||||
proceeds from the sale of assets | 0 | ||||||||||||||||||||||||||||||||
settlement of u.s. treasury rate lock agreements | |||||||||||||||||||||||||||||||||
repayment of convertible debt | |||||||||||||||||||||||||||||||||
capital contribution by joint venture partners | 166,000 | 1,987,000 | 1,400,000 | ||||||||||||||||||||||||||||||
equity in (earnings) of investees, net of dividends | 13,311,000 | -1,551,000 | 7,013,000 | ||||||||||||||||||||||||||||||
cash (utilized) provided by operating activities | |||||||||||||||||||||||||||||||||
adjustments to reconcile net earnings to cash from operating activities: | |||||||||||||||||||||||||||||||||
stock plans tax benefit | 50,000 | 1,267,000 | 11,002,000 | 132,000 | 359,000 | ||||||||||||||||||||||||||||
cash (utilized) provided by investing activities | |||||||||||||||||||||||||||||||||
settlement of treasury rate lock agreements | |||||||||||||||||||||||||||||||||
capital contribution by joint venture partner | 49,000 | 0 | 1,000,000 | ||||||||||||||||||||||||||||||
repayment of corporate-owned life insurance loans | |||||||||||||||||||||||||||||||||
capital contributions from joint venture partners | |||||||||||||||||||||||||||||||||
equity in earnings of investees, net of dividends | 17,124,000 | ||||||||||||||||||||||||||||||||
stock option tax benefit | -500,000 | 147,000 | 637,000 | ||||||||||||||||||||||||||||||
change in operating assets and liabilities | |||||||||||||||||||||||||||||||||
proceeds from sales and maturities of marketable securities | |||||||||||||||||||||||||||||||||
investments | |||||||||||||||||||||||||||||||||
repurchase of common shares | |||||||||||||||||||||||||||||||||
capital contribution from noncontrolling interests | |||||||||||||||||||||||||||||||||
proceeds from maturities of marketable securities | 165,285,000 | 258,541,000 | |||||||||||||||||||||||||||||||
equity in earnings of investees |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
